Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Gold nanorods: from anisotropy to opportunity. An evolution update.

Onaciu A, Braicu C, Zimta AA, Moldovan A, Stiufiuc R, Buse M, Ciocan C, Buduru S, Berindan-Neagoe I.

Nanomedicine (Lond). 2019 May;14(9):1203-1226. doi: 10.2217/nnm-2018-0409. Epub 2019 May 10.

PMID:
31075049
2.

The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis.

Braicu C, Zimta AA, Harangus A, Iurca I, Irimie A, Coza O, Berindan-Neagoe I.

Cancers (Basel). 2019 Apr 30;11(5). pii: E605. doi: 10.3390/cancers11050605. Review.

3.

Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines-Possible Implications in New Therapeutic Strategies.

Budisan L, Gulei D, Jurj A, Braicu C, Zanoaga O, Cojocneanu R, Pop L, Raduly L, Barbat A, Moldovan A, Moldovan C, Tigu AB, Ionescu C, Atanasov AG, Irimie A, Berindan-Neagoe I.

Int J Mol Sci. 2019 Mar 9;20(5). pii: E1199. doi: 10.3390/ijms20051199.

4.

Comprehensive analysis of circular RNAs in pathological states: biogenesis, cellular regulation, and therapeutic relevance.

Braicu C, Zimta AA, Gulei D, Olariu A, Berindan-Neagoe I.

Cell Mol Life Sci. 2019 Apr;76(8):1559-1577. doi: 10.1007/s00018-019-03016-5. Epub 2019 Feb 25. Review.

PMID:
30805658
5.

miR-181a/b therapy in lung cancer: reality or myth?

Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I.

Mol Oncol. 2019 Jan;13(1):9-25. doi: 10.1002/1878-0261.12420. Epub 2019 Jan 3. Review.

6.

Securidaca-saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells.

Obasi TC, Braicu C, Iacob BC, Bodoki E, Jurj A, Raduly L, Oniga I, Berindan-Neagoe I, Oprean R.

Cancer Manag Res. 2018 Nov 15;10:5709-5724. doi: 10.2147/CMAR.S163328. eCollection 2018. Erratum in: Cancer Manag Res. 2019 Jan 15;11:691.

7.

Aberrant miRNAs expressed in HER-2 negative breast cancers patient.

Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I.

J Exp Clin Cancer Res. 2018 Oct 20;37(1):257. doi: 10.1186/s13046-018-0920-2.

8.

Premature senescence activation in DLD-1 colorectal cancer cells through adjuvant therapy to induce a miRNA profile modulating cellular death.

Chira S, Raduly L, Braicu C, Jurj A, Cojocneanu-Petric R, Pop L, Pileczki V, Ionescu C, Berindan-Neagoe I.

Exp Ther Med. 2018 Aug;16(2):1241-1249. doi: 10.3892/etm.2018.6324. Epub 2018 Jun 19.

9.

Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients.

Irimie AI, Braicu C, Cojocneanu R, Magdo L, Onaciu A, Ciocan C, Mehterov N, Dudea D, Buduru S, Berindan-Neagoe I.

Int J Environ Res Public Health. 2018 Jul 23;15(7). pii: E1558. doi: 10.3390/ijerph15071558.

10.

A miRNAs profile evolution of triple negative breast cancer cells in the presence of a possible adjuvant therapy and senescence inducer.

Lajos R, Braicu C, Jurj A, Chira S, Cojocneanu-Petric R, Pileczki V, Berindan-Neagoe I.

J BUON. 2018 May-Jun;23(3):692-705.

11.

The foundation of personalized medicine is the establishment of biobanks and their standardization.

Policiuc L, Buse M, Gulei D, Andreea Zimta A, Braicu C, Iulia Irimie A, Berindan-Neagoe I.

J BUON. 2018 May-Jun;23(3):550-560.

12.

In Vitro Transcriptome Response to a Mixture of Lactobacilli Strains in Intestinal Porcine Epithelial Cell Line.

Taranu I, Marin DE, Braicu C, Pistol GC, Sorescu I, Pruteanu LL, Berindan Neagoe I, Vodnar DC.

Int J Mol Sci. 2018 Jun 30;19(7). pii: E1923. doi: 10.3390/ijms19071923.

13.

RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.

Buduru S, Zimta AA, Ciocan C, Braicu C, Dudea D, Irimie AI, Berindan-Neagoe I.

Int J Nanomedicine. 2018 Jun 8;13:3397-3409. doi: 10.2147/IJN.S167383. eCollection 2018. Review.

14.

Decoding the Emerging Patterns Exhibited in Non-coding RNAs Characteristic of Lung Cancer with Regard to their Clinical Significance.

Sonea L, Buse M, Gulei D, Onaciu A, Simon I, Braicu C, Berindan-Neagoe I.

Curr Genomics. 2018 May;19(4):258-278. doi: 10.2174/1389202918666171005100124.

15.

The Unforeseen Non-Coding RNAs in Head and Neck Cancer.

Irimie AI, Zimta AA, Ciocan C, Mehterov N, Dudea D, Braicu C, Berindan-Neagoe I.

Genes (Basel). 2018 Mar 1;9(3). pii: E134. doi: 10.3390/genes9030134. Review.

16.

Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer.

Zanoaga O, Jurj A, Raduly L, Cojocneanu-Petric R, Fuentes-Mattei E, Wu O, Braicu C, Gherman CD, Berindan-Neagoe I.

Exp Ther Med. 2018 Feb;15(2):1167-1176. doi: 10.3892/etm.2017.5515. Epub 2017 Nov 16.

17.

A Looking-Glass of Non-coding RNAs in oral cancer.

Irimie AI, Braicu C, Sonea L, Zimta AA, Cojocneanu-Petric R, Tonchev K, Mehterov N, Diudea D, Buduru S, Berindan-Neagoe I.

Int J Mol Sci. 2017 Dec 5;18(12). pii: E2620. doi: 10.3390/ijms18122620. Review.

18.

Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia?

Boca S, Berce C, Jurj A, Petrushev B, Pop L, Gafencu GA, Selicean S, Moisoiu V, Temian D, Micu WT, Astilean S, Braicu C, Tomuleasa C, Berindan-Neagoe I.

Med Hypotheses. 2017 Nov;109:42-45. doi: 10.1016/j.mehy.2017.09.023. Epub 2017 Sep 27.

PMID:
29150291
19.

Molecular-trapping in Emulsion's Monolayer: A New Strategy for Production and Purification of Bioactive Saponins.

Obasi TC, Moldovan R, Toiu A, Braicu C, Bodoki E, Berindan-Neagoe I, Oniga I, Sandulescu R, Oprean R.

Sci Rep. 2017 Nov 6;7(1):14511. doi: 10.1038/s41598-017-15067-4.

20.

The new era of nanotechnology, an alternative to change cancer treatment.

Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I.

Drug Des Devel Ther. 2017 Sep 27;11:2871-2890. doi: 10.2147/DDDT.S142337. eCollection 2017. Review.

Supplemental Content

Loading ...
Support Center